Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1998
12/30/1998WO1998058957A2 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
12/30/1998WO1998058955A2 Nuclear matrix targeting peptides and uses therefor
12/30/1998WO1998058954A2 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
12/30/1998WO1998058953A2 Surface exposed proteins from chlamydia pneumoniae
12/30/1998WO1998058952A1 Angiotensin derivatives
12/30/1998WO1998058950A1 Compounds with growth hormone releasing properties
12/30/1998WO1998058945A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor
12/30/1998WO1998058943A1 Borrelia burgdorferi polynucleotides and sequences
12/30/1998WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases
12/30/1998WO1998058674A1 Anti-tumour pharmaceutical compositions capable of reducing drug resistance in tumour cells
12/30/1998WO1998058541A1 Modulation of apoptosis
12/30/1998WO1998058536A1 Transgenic rabbits expressing cd4 and chemokine receptor
12/30/1998WO1998044944A3 Stabilized human papillomavirus formulations
12/30/1998WO1998044115A3 Regulators of g-protein signalling
12/30/1998WO1998044097A3 Method for enhancing expression of a foreign or endogenous gene product in plants
12/30/1998WO1998040404A3 Secreted proteins and polynucleotides encoding them
12/30/1998EP0887417A2 Method of producing a 19P2 ligand by cleavage of a fusion protein containing it
12/30/1998EP0887416A2 Human AFC1
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887412A1 Recombinant birnavirus vaccine
12/30/1998EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae
12/30/1998EP0887410A2 DNA encoding a plasminogen activating protein
12/30/1998EP0887409A1 Chemokine MIG-beta: cDNA fragment, protein, expression vector, transformed cell, diagnosis methods and pharmaceutical composition
12/30/1998EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides
12/30/1998EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
12/30/1998EP0887406A2 A member of the FRZB family, franzzled
12/30/1998EP0887404A1 Gene that imparts selective proliferative activity
12/30/1998EP0886680A1 Virus-like particle
12/30/1998EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines
12/30/1998EP0886678A1 Export systems for recombinant proteins
12/30/1998EP0886652A1 Pulmonary surfactant peptide solubilization process
12/30/1998EP0886651A1 Persephin and related growth factors
12/30/1998EP0886650A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
12/30/1998EP0886649A1 Protein occlusion for delivery of small molecules
12/30/1998EP0886648A1 Compounds and peptides that bind to the erythropoietin receptor
12/30/1998EP0886646A1 Novel compounds
12/30/1998EP0886644A1 Long wavelength engineered fluorescent proteins
12/30/1998EP0886643A1 Human g-protein chemokine receptor hsatu68
12/30/1998EP0886642A1 Immune cell cytokine
12/30/1998EP0886477A1 Ice crystal growth inhibiting agents
12/30/1998EP0750637B1 Dna encoding cai resistance proteins and uses thereof
12/30/1998EP0705105A4 Metal chelates as spacer compounds in biologically active peptides
12/30/1998EP0698038B1 Method of separating glycosylated and non-glycosylated proteins
12/30/1998EP0686164B1 Intrinsic inhibitors of aldose reductase
12/30/1998EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines
12/30/1998EP0633945B1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
12/30/1998EP0591384B1 Attenuated revertant serotype 1 marek's disease vaccine
12/30/1998EP0584273B1 Antibody recognizing endothelial cell ligand for leukocyte cr3
12/30/1998EP0553244B1 Targeted immunostimulation with bispecific reagents
12/30/1998EP0463059B1 Allergenic proteins from ragweed and uses therefor
12/30/1998CN1203633A Diagnosis of susceptibility to cancer and treatment thereof
12/30/1998CN1203632A P16 expression constructs and their application in cancer therapy
12/30/1998CN1203631A Constructs and methods for enhancing protein levels in photosynthetic organisms
12/30/1998CN1203630A 治疗和诊断组合物 Therapeutic and diagnostic compositions
12/30/1998CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies
12/30/1998CN1203532A Method for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product
12/30/1998CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product
12/30/1998CN1203274A Microorganisms and processes for fermentative preparation of L-cysteine, L-cystine, N-acetylserine or thiazolidine derivatives
12/30/1998CN1203238A Novel insulin derivatives having rapid onset of action
12/30/1998CA2594375A1 Bovine adenovirus type 3 genome
12/30/1998CA2304925A1 Borrelia burgdorferi polynucleotides and sequences
12/30/1998CA2296814A1 Treponema pallidum polynucleotides and sequences
12/30/1998CA2296008A1 Rice beta-glucanase enzymes and genes
12/30/1998CA2296002A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
12/30/1998CA2295989A1 Pathogen-resistant monocot plants and method
12/30/1998CA2295210A1 Prolactin secretion modulator
12/30/1998CA2295200A1 Receptor kinase, bin1
12/30/1998CA2295059A1 Transgenic rabbits expressing cd4 and chemokine receptor
12/30/1998CA2294651A1 Surface exposed proteins from chlamydia pneumoniae
12/30/1998CA2294648A1 Improved enterobacteriaceae fermentation strains
12/30/1998CA2294568A1 Lyme disease vaccines
12/30/1998CA2294468A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor
12/30/1998CA2294257A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds
12/30/1998CA2294195A1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor
12/30/1998CA2294119A1 Expression system for production of therapeutic proteins
12/30/1998CA2293999A1 Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of relatedproteins
12/30/1998CA2293661A1 Reagents and methods useful for detecting diseases of the breast
12/30/1998CA2292844A1 D-amino acid oxidase promoter from t. variabilis
12/30/1998CA2292644A1 Receptor for a bacillus thuringiensis toxin
12/30/1998CA2292415A1 B7-binding molecules for treating immune diseases
12/29/1998US5854418 Kaposi's sarcoma-associated herpesvirus (KSHV) viral macrophage inflammatory protein-1α II (vMIP-1α II) and uses thereof
12/29/1998US5854417 Borna disease virus-specific DNA and proteins
12/29/1998US5854416 Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
12/29/1998US5854415 Methods for the diagnosis of glaucoma
12/29/1998US5854414 Human mitochondrial membrane protein
12/29/1998US5854413 Synaptogyrin homolog
12/29/1998US5854412 Chemokine N-terminal deletion mutations
12/29/1998US5854411 Human chloride channel
12/29/1998US5854404 Antitumor substance extracted from grifola
12/29/1998US5854403 Method for isolation of highly pure von Willebrand Factor
12/29/1998US5854399 Antibodies specific for human cripto-related polypeptide CR-3
12/29/1998US5854398 Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
12/29/1998US5854397 Processs for cross-linking collagenous material
12/29/1998US5854396 Protein, DNA coding for same and method of producing the protein
12/29/1998US5854395 Cloned borrelia burgdorferi virulence protein
12/29/1998US5854392 β APP-C100 receptor
12/29/1998US5854389 Process for preparing modified proteins
12/29/1998US5854388 Angiotensin IV peptides and receptor
12/29/1998US5854387 Simple method for the purification of a bioelastic polymer
12/29/1998US5854220 Glial mitogenic factors, their preparation and use